2013 ACR/ARHP Annual Meeting

October 25-30, 2013. San Diego, CA.

View by Title View Sessions

Jump to: View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

Abstract Number: 21

Factor Xa Reactive Antibodies In Patients With Systemic LUPUS Erythematosus and Antiphospholipid Syndrome Have Differential Effects Upon Coagulation Assays and Endothelial CELLS
Abstract Number: 2292

Factors Affecting The Discrepancy Between Physician and Patient Global Assessment Of Disease Activity In Early and Established Rheumatoid Arthritis Patients- Results From The Ontario Best Practices Initiative
Abstract Number: 603

Factors Associated With a Double Increase In Serum Creatinine In Biopsy Proven Lupus Nephritis From a Single Center In Spain
Abstract Number: 1027

Factors Associated With Decisions To Adjust Therapy For Rheumatoid Arthritis Patients In Moderate To High Disease Activity
Abstract Number: 600

Factors Associated With Long-Term Renal Function Deterioration In Lupus Nephritis Treated Initially With Combined Prednisolone and Mycophenolate Mofetil (MMF) Or Tacrolimus (Tac)
Abstract Number: 2130

Factors Associated With Two-Year Pain Experience Outcome In Knee Osteoarthritis
Abstract Number: 347

Factors Explaining The Discrepancy Between Patient and Physician Global Assessment Of Disease Activity In Psoriatic Arthritis
Abstract Number: 1350

Factors Influencing Selection Of Biologic Therapy and Comparative Effectiveness In Patient Reported Outcomes Among Patients With Rheumatoid Arthritis
Abstract Number: 832

Factors That Affect Tender and Swollen Joint Counts In Rheumatoid Arthritis
Abstract Number: 1917

Falls Among Hospitalized Orthopedic Patients: A Prospective Case-Control Study
Abstract Number: 180

Familial Aggregation Of Female Premenopausal Gout –Monogenic, Polygenic Or Clinical Coincidence?
Abstract Number: 2235

Fas Signaling In Macrophages Promotes Chronicity In K/BxN Serum Transfer Induced Arthritis
Abstract Number: 2667

Fast-Track Pathway In Giant Cell Arteritis: A Cost-Effectivenss Analysis
Abstract Number: 2474

Fat Mass and Resistin: Predictive Factors For Anti-TNF Therapy Response In Ankylosing Spondylitis Patients
Abstract Number: 337

Fatigue and Work Disability In Psoriatic Arthritis
Abstract Number: 1125

Fatigue In Ankylosing Spondylitis Is Associated With The Brain Networks Of Sensory Salience and Attention
Abstract Number: 2717

Fatigue in Rheumatoid Arthritis Is Associated With Modifiable Lifestyle Factors
Abstract Number: 885

Fatigue In SLE Is Associated With Upregulation Of Interferon- Alpha Related Gene Transcripts
Abstract Number: 751

Fatigue, Pain, and Functional Disability Among Patients With Vasculitis
Abstract Number: 2200

Fatty Acid Profiling In Juvenile Idiopathic Arthritis: The Balance Between Pro-Inflammatory and Pro-Resolving Prostanoids
Abstract Number: 1574

Favorable Clinical Response To Belimumab At Three Months
Abstract Number: 2808

Favorable Outcome Of Hepatitis E Virus Infection In Patients With Inflammatory Arthritides Treated With Immunosupressants
Abstract Number: 178

Fc-Gamma Receptor Genetic Variation In Kawasaki Disease
Abstract Number: 1257

Feasibility and Clinical Implications Of The Pediatric Automated Neuropsychological Assessment Metrics for Screening Of Childhood-Onset Neuropsychiatric Systemic Lupus Erythematosus
Abstract Number: 2631

Fertility In Behçet’s Syndrome: Structured Interview In A Multidisciplinary Center
Abstract Number: 73

Fibrillin-1 Expression and Function Is Needed For Normal Joint Function and Mutations Leads To Osteoarthritis
Abstract Number: 1088

Fibromyalgia and Parental Medical Histories Of Depression and Alcoholism
Abstract Number: 140

Fibromyalgia and Pregnancy: Challenges Of The Savella^® (Milnacipran) Pregnancy Registry
Abstract Number: 840

Fibromyalgia, Somatic Symptoms, and Mental Illness In View Of The 2013 Diagnostic and Statistical Manual Of Mental Disorders
Abstract Number: 64

Fibulin-3 In Joint Aging and Osteoarthritis Pathogenesis
Abstract Number: 1414

Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized Placebo-Controlled Trial Of Golimumab In Patients With Active Rheumatoid Arthritis Despite Prior Treatment With Methotrexate
Abstract Number: 435

Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized, Placebo-Controlled Trial Of Golimumab In Methotrexate-naïve Patients With Rheumatoid Arthritis
Abstract Number: 2325

Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized, Placebo-Controlled Trial Of Golimumab In Patients With Active Rheumatoid Arthritis Despite Previous Anti-Tumor Necrosis Factor Therapy
Abstract Number: 1883

Fine Mapping and Expression Of a Locus Overlapping 3 Types Of Inflammatory Arthritis
Abstract Number: 1706

Fine-Mapping Major Histocompatibility Complex Variation Associated With Ankylosing Spondylitis Susceptibility
Abstract Number: 2830

First Stage Of a Simon’s Two-Stage Optimal Approach Supports Placental Transfer Of Hydroxychloroquine and a Reduced Recurrence Rate Of The Cardiac Manifestations Of Neonatal Lupus
Abstract Number: 500

Fixed Versus On-Flare Retreatment With Rituximab In RA – Results From The Cererra Collaboration
Abstract Number: 558

Fli-1 Regulates Immune Cell Infiltration Through Affecting Local Chemokine Expression and IL-6 Expression In The Kidney Of Lupus Prone Mice
Abstract Number: 2706

Fli1 Haploinsufficiency Exacerbates Dermal Fibrosis Via Activation Of Fibroblasts, Endothelial Cells and Macrophages In Bleomycin-Treated Mice
Abstract Number: 2823

FLIP Deficiency In Dendritic Cells Promotes Spontaneous Inflammatory and Erosive Arthritis
Abstract Number: 2557

Fluctuations In sVCAM-1 and Adiponectin Mirror Fluctuations In Disease Activity In Lupus, But Cannot Be Use To Accurately Predict Impending Changes In Disease State
Abstract Number: 2228

FMS-Like Tyrosine Kinase 3 Ligand -Dependent CD103+DC Are Crucial For The Initiation Of Collagen-Induced Arthritis
Abstract Number: 920

Fms-Like Tyrosine Kinase 3 Signaling Is Essential For Differentiation Of Antigen Specific Plasma Cells During Experimental Arthritis
Abstract Number: 209

Focus on cardiovascular Risk Factor Recording In a Rheumatology Outpatient Clinic
Abstract Number: 1711

Folic Acid Prescription Among Older Adult Methotrexate Initiators Is Poor
Abstract Number: 37

Follicular Entry Of Lymphotoxin-Expressing B Cells Via Type I Interferon Disrupts Marginal Zone Barrier Integrity and Exacerbates Systemic Autoimmunity
Abstract Number: 66

Follistatin-Like Protein 1 Is An Important Regulator Of Chondrogenesis
Abstract Number: 2304

Follow-Up Of Patients With Preclinical Rheumatoid Arthritis – Results Of a Telephone Survey
Abstract Number: 2810

Follow-Up Testing Of Interferon-Gamma Release Assays For The Diagnosis Of Hidden Tuberculosis Infection In Patients Receiving Tumor Necrosis Factor Alpha Antagonists
Abstract Number: 899

Foot Pain, But Not Foot Structure Or Foot Function, Are Associated With Self-Reported Physical Limitations: The Framingham Foot Study
Abstract Number: 900

Foot Symptoms Increase Odds Of Falling: The Johnston County Osteoarthritis Project
Abstract Number: L14

For Remission Induction with Glucocorticoid Bridging, Methotrexate Monotherapy Is As Effective As a Combination with Other Dmards, with Fewer Reported Side Effects: 4 Month Primary Outcome of Carera, a Randomized Induction Strategy and Treat to Target Trial in Early RA
Abstract Number: 1049

Formal Education Level Explains Variation In Rheumatoid Arthritis (RA) Core Data Set Measures and Indices In Korean Patients At Higher Levels Of Significance Than Age, Sex, and Duration Of Disease
Abstract Number: 664

Formate, Acetate and Acetone : News Biomarkers in Systemic Sclerosis identified by Metabolomics
Abstract Number: 1225

FRAX 10-Year Fracture Risk In Women With a Fracture Of The Distal Forearm: Agreement Between Assessments With and Without Bone Mineral Density and Influence Of Measurement Side In Individual Patients
Abstract Number: 207

Frequency and Predictors Of Hypertension Communication In Rheumatoid Arthritis Visits
Abstract Number: 128

Frequency Of Axial Spondyloarthropathy Among Patients Suffering From Fibromyalgia A Magnetic Resonance Immaging Study With Application Of The Assessment Of Spondylo-Arthritis International Society Classification Criteria
Abstract Number: 2888

Frequent Detection Of Inflammation and Fat Infiltration Suggestive Of Spondyloarthritis On MRI Of The Entire Spine In Healthy Subjects and Patients With Mechanical Back Pain
Abstract Number: 2564

Functional Activation Of The TRPV1 and TRPV2 Non-Selective Cation Channels Potentiates TGF-β1-Induced Endothelial-To-Mesenchymal Transition In Murine Pulmonary Endothelial Cells Suggest a Potential Role Of Trpv Channels In The Pathogenesis Of Systemic Sclerosis
Abstract Number: 1340

Functional Disability and Quality Of Life Are More Likely Improved In Patients With Rheumatoid Arthritis Who Achieved The New ACR/EULAR Remission Criteria Compared To DAS28 Remission In Daily Practice
Abstract Number: 1629

Functional Effect Of NR1H3 (LXRA) Promoter Polymorphisms In Korean Patients With Systemic Lupus Erythematosus
Abstract Number: 2347

Functional Single Nucleotide Polymorphisms In The Interferon-γ and The NLRP3 (Cryopyrin) Genes Associated With Anti-TNF Response In Danish Rheumatoid Arthritis Patients
Abstract Number: 2492

Functionally Distinct ERAP1 Haplotype Combinations Distinguish Individuals With Ankylosing Spondylitis
Abstract Number: 1853

Functions Of Aminopeptidase N/CD13 In Vitro On Rheumatoid Arthritis Synovial Cells
Abstract Number: 864

Further Reduction In Nonvertebral Fracture Rate Is Observed Following 3 Years Of Denosumab Treatment: Results With Up To 7 Years In The Freedom Extension

Jump to: View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].